Radioactive drugs public meeting
FDA will hold a public meeting Nov. 16 to consider whether the 1975 regulation on radioactive drugs for research use adequately addresses safety issues, a 1notice in the Oct. 5 Federal Register says. The agency is seeking input on whether new guidance should be developed or the current reg should be revised based on new developments in the field...
You may also be interested in...
ABHI’s Phil Brown believes the future of UK device regulation will be innovation-friendly and patient-responsive system – but doesn’t expect easy alignment with the EU. See what he had to say.
Biologics license application is preferred route to market, but if emergency authorization is given it should happen with full transparency and be communicated in a clear manner to strengthen public confidence, National Vaccine Advisory Committee says.
With the meetings available on television, access can be assured for just about everyone, and the US FDA can avoid another gut punch to its credibility.